AP
AMEX · APUS
Apimeds Pharmaceuticals US, Inc
Healthcare · Drug Manufacturers - Specialty & Generic
$4.59
Up+$2.54 (+55.34%)
Updated Oct 6, 2026, 9:26 PM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 17.1M
- P/E ratio
- -3.32
- Dividend yield
- 0.00%
- 52-week range
- $0.62 – $21.00
- Volume
- 33.79M
- Avg. volume
- 163.68K
Price performance · APUS
APUS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
APUS closed at $4.59 after 20 trading sessions, up 99.57% for the selected period.
- Last close
- $4.59
- Period change
- +99.57%
- Period low
- $1.60
- Period high
- $7.25
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $4.99 | $5.83 | $4.21 | $4.59 | 33.79M |
| Oct 2, 2026 | $4.10 | $4.16 | $3.10 | $3.22 | 138.72K |
| Oct 1, 2026 | $4.90 | $5.09 | $4.10 | $4.10 | 146.51K |
| Sep 30, 2026 | $5.04 | $5.25 | $4.72 | $5.00 | 191.51K |
| Sep 29, 2026 | $6.17 | $6.17 | $4.63 | $5.02 | 768.44K |
| Sep 28, 2026 | $6.33 | $6.50 | $5.56 | $6.39 | 858.8K |
| Sep 25, 2026 | $8.32 | $9.14 | $5.39 | $7.25 | 37.11M |
| Sep 24, 2026 | $6.99 | $8.74 | $4.61 | $4.92 | 87.85M |
| Sep 23, 2026 | $1.81 | $2.30 | $1.7446 | $2.29 | 152.53K |
| Sep 22, 2026 | $1.65 | $1.999 | $1.6128 | $1.85 | 134.82K |
| Sep 21, 2026 | $1.72 | $1.865 | $1.67 | $1.67 | 671.01K |
| Sep 18, 2026 | $1.68 | $2.10 | $1.6301 | $1.77 | 1.34M |
| Sep 17, 2026 | $1.73 | $1.92 | $1.60 | $1.67 | 84K |
| Sep 16, 2026 | $1.71 | $1.71 | $1.51 | $1.60 | 65.03K |
| Sep 15, 2026 | $2.11 | $2.1101 | $1.60 | $1.64 | 66.3K |
| Sep 14, 2026 | $2.39 | $2.39 | $2.025 | $2.09 | 29.82K |
| Sep 11, 2026 | $2.16 | $2.26 | $2.09 | $2.105 | 20.69K |
| Sep 10, 2026 | $2.26 | $2.47 | $2.12 | $2.17 | 41.16K |
| Sep 9, 2026 | $2.30 | $2.35 | $2.17 | $2.29 | 29.57K |
| Sep 8, 2026 | $2.40 | $2.405 | $2.25 | $2.30 | 17.42K |
Latest APUS news
The latest Smart Investors Daily articles mentioning APUS.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…
